Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Radnet Inc (RDNT)

Radnet Inc (RDNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,169,591
  • Shares Outstanding, K 57,361
  • Annual Sales, $ 1,315 M
  • Annual Income, $ 24,730 K
  • 60-Month Beta 1.54
  • Price/Sales 0.83
  • Price/Cash Flow 5.15
  • Price/Book 2.52
Trade RDNT with:

Options Overview Details

View History
  • Implied Volatility 45.88% ( -0.92%)
  • Historical Volatility 30.84%
  • IV Percentile 26%
  • IV Rank 20.27%
  • IV High 88.11% on 06/14/22
  • IV Low 35.14% on 08/16/22
  • Put/Call Vol Ratio 4.16
  • Today's Volume 129
  • Volume Avg (30-Day) 197
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 2,225
  • Open Int (30-Day) 2,765

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.19
  • Number of Estimates 2
  • High Estimate 0.21
  • Low Estimate 0.16
  • Prior Year 0.13
  • Growth Rate Est. (year over year) +46.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.82 +14.25%
on 01/06/23
20.96 -2.86%
on 01/23/23
+1.55 (+8.24%)
since 12/27/22
3-Month
12.03 +69.24%
on 11/09/22
21.24 -4.14%
on 12/08/22
+1.56 (+8.30%)
since 10/27/22
52-Week
12.03 +69.24%
on 11/09/22
26.84 -24.15%
on 02/09/22
-3.77 (-15.62%)
since 01/27/22

Most Recent Stories

More News
5 Toxic Stocks That Can Set Off Alarm Bells for Your Portfolio

Investors who can correctly spot overpriced stocks and shun them at the right time can avoid big losses. Dump toxic stocks like MGM, ILMN, OMCL, HL and RDNT to prevent portfolio bleeding.

OMCL : 57.54 (+3.12%)
ILMN : 214.03 (+0.59%)
MGM : 41.01 (+0.24%)
RDNT : 20.36 (-0.15%)
HL : 6.24 (-2.04%)
Delaware Imaging Network Launches the Enhanced Breast Cancer Detection Program, Providing Women a New State-of-the-Art Solution Powered by Artificial Intelligence

/PRNewswire/ -- Delaware Imaging Network, a division of RadNet, Inc. (NASDAQ: RDNT), today announced that it has started implementation of its new Enhanced...

RDNT : 20.36 (-0.15%)
RadNet (RDNT) Misses Q3 Earnings and Revenue Estimates

RadNet (RDNT) delivered earnings and revenue surprises of -43.75% and 0.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

RDNT : 20.36 (-0.15%)
WRBY : 16.73 (+1.58%)
Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Top Estimates

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 25% and 0.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for...

ELAN : 14.06 (+1.30%)
RDNT : 20.36 (-0.15%)
Encompass Health (EHC) Q3 Earnings Miss Estimates

Encompass Health (EHC) delivered earnings and revenue surprises of -1.47% and 2.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

EHC : 61.39 (-0.68%)
RDNT : 20.36 (-0.15%)
Is RadNet (RDNT) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

RDNT : 20.36 (-0.15%)
Should Value Investors Buy Quest Diagnostics (DGX) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

DGX : 145.63 (-0.91%)
RDNT : 20.36 (-0.15%)
RadNet (RDNT) Stock Jumps 16%: Will It Continue to Soar?

RadNet (RDNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

RDNT : 20.36 (-0.15%)
GBNH : 2.18 (+0.46%)
Is Quest Diagnostics (DGX) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

DGX : 145.63 (-0.91%)
RDNT : 20.36 (-0.15%)
RadNet (RDNT) Tops Q2 Earnings and Revenue Estimates

RadNet (RDNT) delivered earnings and revenue surprises of 200% and 1.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

RDNT : 20.36 (-0.15%)
AVAH : 1.2700 (-3.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT,...

See More

Key Turning Points

3rd Resistance Point 21.35
2nd Resistance Point 21.00
1st Resistance Point 20.68
Last Price 20.36
1st Support Level 20.02
2nd Support Level 19.68
3rd Support Level 19.36

See More

52-Week High 26.84
Fibonacci 61.8% 21.18
Last Price 20.36
Fibonacci 50% 19.44
Fibonacci 38.2% 17.69
52-Week Low 12.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar